Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from <i>Pseudomonas aeruginosa</i>.

Publication Year: 2022

DOI:
10.1021/acsinfecdis.1c00628

PMCID:
PMC9112332

PMID:
35451824

Journal Information

Full Title: ACS Infect Dis

Abbreviation: ACS Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declare the following competing financial interest(s): The authors declare the following financial interest(s): C.K, I.W., J.K, J.H., R.W.H and A.K.H.H are co-inventors on a pending international patent application (PCT/EP2021/073381) that incorporates compounds and methods outlined in this manuscript."

Evidence found in paper:

"The authors thank Prof. Dr. Aránzazu Del Campo from Leibniz Institute for New Materials (INM) (Saarbrücken, Germany) for providing the NHDF cells, Khadidja Si Chaib for helping in testing the activity of the supernatant, and Martina Wiesbauer for the determination of ColH activities. They also thank the group of Susanne Häussler (Twincore, Hannover, Germany) for providing the P. aeruginosa ΔlasB PA14 strain. The authors are grateful for the technical support provided by Simone Amann, Jeannine Jung, Selina Wolter, and Dennis Jener. A.K.H.H. gratefully acknowledges funding from the Helmholtz Association’s Initiative and Networking Fund and by CARB-X. J.K. acknowledges funding by the Alexander von Humboldt Foundation and E.S. by the Austrian Science Fund (P 31843). Open Access is funded by the Austrian Science Fund (FWF)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025